Deeply cultivate the internationalization of traditional Chinese medicine with craftsmanship and create a new benchmark for the health industry

Recently, Hefei Amedcare Import and Export Trade Co., Ltd. has once again attracted industry attention with its innovative breakthroughs and global layout in the field of traditional Chinese medicine and health. As the core foreign trade department of Anhui Dongshen Pharmaceutical Co., Ltd., Hefei Amedcare has always taken "inheriting herbal wisdom and innovating a healthy future" as its mission. Through the GMPPGSP dual certification system, modern production base and full-chain services, it has steadily moved towards the ranks of benchmark companies for the internationalization of traditional Chinese medicine.

Dual certification escorts quality, and intelligent manufacturing enables production

Since its establishment in 2011, Hefei Amedcare has always regarded quality as its lifeline. The company's production base covers an area of 18,000 square meters, equipped with 3 standardized production workshops, 2 smart warehouses and independent laboratories, and strictly follows GMP standards for full-process control. From raw material screening to finished product delivery, every link is traceable in data to ensure that core products such as pure herbal concentrated pills and syrup oral liquids meet the EU CE certification and market access requirements of multiple countries. In 2023, the production base will be upgraded to intelligentization, and the automated production line and intelligent warehousing system will increase the production capacity by 30%, shorten the order delivery cycle to within 15 days, and respond efficiently to the needs of global customers.

Innovation drives the product matrix, serving the global market in all scenarios

Relying on the research and development strength of Dongshen Pharmaceutical, Amedcare continues to deepen the field of herbal health and form a full-scenario solution covering "prevention-conditioning-maintenance". Its product line covers pure herbal concentrated pills, capsules, functional syrups, zero-additive herbal teas and slimming teas and other major health categories, and launches "physique testing + product customization" services to match users with personalized health plans through online platforms and cooperative clinics. For corporate customers, the company provides OEMODM one-stop services and has reached cooperation with brands in more than 30 countries and regions such as Southeast Asia and Europe, helping Chinese medicine culture go global.

Customer-first commitment, digital strategy leads the future

Amedcare adheres to the "customer-centric" principle and establishes a 24-hour after-sales response mechanism. The satisfaction rate of quality problem handling within the validity period of the product reaches 98%. In 2025, the company launched a digital strategy and built a cross-border e-commerce platform to achieve full-link visualization of orders, production, and logistics, so that customers can track product status in real time. In the future, Amedcare will continue to deepen industry-university-research cooperation, focus on the modernization and improvement of herbal formulas, and inject oriental power into the global health industry with "Chinese herbs + global wisdom" as the core.

From traditional manufacturing to intelligent manufacturing, from product exports to brand output, Hefei Amedcare is sailing towards the deep blue sea of internationalization of traditional Chinese medicine with innovation as the paddle and quality as the sail.